🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSemaglutide and gallbladder disease risk — my results so far Page 8

Semaglutide and gallbladder disease risk — my results so far

lisa_labSD Wed, Jun 4, 2025 at 10:48 PM 44 replies 2,339 viewsPage 8 of 9
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Jan 16, 2026 at 12:05 AM#36
hans_munich said:
It helps to ask what evidence would change your mind before you look at any.

This matches mine closely enough to be worth saying so out loud.

21 19rachel_ABQ, traveltech_sara, AttorneyGrant and 18 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Jan 28, 2026 at 7:16 PM#37
hans_munich said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

22 20pam_stl, wei_SG, cory_ATX and 19 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Feb 10, 2026 at 2:20 PM#38

The figures, for anyone assembling their own picture. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Last edited: Feb 10, 2026 at 5:20 PM
23 21Dr.SleepRoch, laura_annarbor, JenMemphis and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Feb 23, 2026 at 9:17 AM#39

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Feb 23, 2026 at 3:17 PM
24 22andrew_nyc, Dr.EndoEP, GraceAZ_72 and 21 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Mar 8, 2026 at 4:06 AM#40
LabKate said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

I read this differently from LabKate, on substance rather than tone. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

I would rather be corrected than agreed with, if it comes to it.

46 19B12Beth, RickReta_CO, PharmHunterJen and 43 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register